Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prophylaxis and treatment of venous thromboembolism in patients with cancer.

× No keyword cloud information.

15 in total

1. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.

Authors: Alexander T Cohen; Bruce L Davidson; Alexander S Gallus; Michael R Lassen; Martin H Prins; Witold Tomkowski; Alexander G G Turpie; Jan F M Egberts; Anthonie W A Lensing
Journal: BMJ Date: 2006-01-26

Review 2. Prophylaxis and treatment of venous thromboembolism in patients with cancer: an update.

Authors: Michela Falciani; Davide Imberti; Domenico Prisco
Journal: Intern Emerg Med Date: 2006 Impact factor: 3.397

3. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.

Authors: David Bergqvist; Giancarlo Agnelli; Alexander T Cohen; Amiram Eldor; Paul E Nilsson; Anne Le Moigne-Amrani; Flavia Dietrich-Neto
Journal: N Engl J Med Date: 2002-03-28 Impact factor: 91.245

4. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients.

Authors: Melina Verso; Giancarlo Agnelli; Sergio Bertoglio; Franco C Di Somma; Francesco Paoletti; Walter Ageno; Mario Bazzan; Pasquale Parise; Roberto Quintavalla; Emanuele Naglieri; Armando Santoro; Davide Imberti; Mariella Sorarù; Stefano Mosca
Journal: J Clin Oncol Date: 2005-03-14 Impact factor: 44.544

5. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.

Authors: M M Samama; A T Cohen; J Y Darmon; L Desjardins; A Eldor; C Janbon; A Leizorovicz; H Nguyen; C G Olsson; A G Turpie; N Weisslinger
Journal: N Engl J Med Date: 1999-09-09 Impact factor: 91.245

6. Risk factors for major thromboembolism and bleeding tendency after elective general surgical operations. The Fragmin Multicentre Study Group.

Authors: P A Flordal; D Berggvist; U S Burmark; K G Ljungström; S Törngren
Journal: Eur J Surg Date: 1996-10

Review 7. Venous thromboembolism and cancer: risks and outcomes.

Authors: Agnes Y Y Lee; Mark N Levine
Journal: Circulation Date: 2003-06-17 Impact factor: 29.690

8. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

Authors: Paolo Prandoni; Anthonie W A Lensing; Andrea Piccioli; Enrico Bernardi; Paolo Simioni; Bruno Girolami; Antonio Marchiori; Paola Sabbion; Martin H Prins; Franco Noventa; Antonio Girolami
Journal: Blood Date: 2002-07-12 Impact factor: 22.113

9. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures.

Authors: Richard H White; Hong Zhou; Patrick S Romano
Journal: Thromb Haemost Date: 2003-09 Impact factor: 5.249

10. Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study.

Authors: Guy Meyer; Zora Marjanovic; Judith Valcke; Bernard Lorcerie; Yves Gruel; Philippe Solal-Celigny; Christine Le Maignan; Jean Marc Extra; Paul Cottu; Dominique Farge
Journal: Arch Intern Med Date: 2002 Aug 12-26

1 in total

Review 1. Portal vein thrombosis in liver cirrhosis.

Authors: Filippo Luca Fimognari; Francesco Violi
Journal: Intern Emerg Med Date: 2008-02-15 Impact factor: 3.397

1 in total